ECSP982539A - INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER - Google Patents

INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER

Info

Publication number
ECSP982539A
ECSP982539A ECSP982539A ECSP982539A EC SP982539 A ECSP982539 A EC SP982539A EC SP982539 A ECSP982539 A EC SP982539A EC SP982539 A ECSP982539 A EC SP982539A
Authority
EC
Ecuador
Prior art keywords
inhibitors
hmg coa
coa reductase
cancer treatment
combined
Prior art date
Application number
Other languages
English (en)
Inventor
Shama Mohammed Kajiji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982539 priority Critical patent/ECSP982539A/es
Publication of ECSP982539A publication Critical patent/ECSP982539A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un procedimiento para tratar cáncer en un mamífero, incluida un ser humano, administrando al citado mamífero un inhibidor de la FTSA combinado con un inhibidor de la HMG CoA.
ECSP982539 1998-06-16 1998-06-16 INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER ECSP982539A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982539 ECSP982539A (es) 1998-06-16 1998-06-16 INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982539 ECSP982539A (es) 1998-06-16 1998-06-16 INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER

Publications (1)

Publication Number Publication Date
ECSP982539A true ECSP982539A (es) 1999-02-11

Family

ID=42043459

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982539 ECSP982539A (es) 1998-06-16 1998-06-16 INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER

Country Status (1)

Country Link
EC (1) ECSP982539A (es)

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
BR9508245A (pt) Método para inhibir metástase de cáncer por administração oral de pectina citrica modificada solúvel
BR0316238A (pt) Quimioterapia de associação compreendendo um inibidor de mek e capecitabina para tratamento de câncer
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
IL147017A0 (en) TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
BR9710686A (pt) Método de tratamento de tumores malignos com tiroxinas análogas não possuindo atividade hormonal siginificativa.
EA200500859A1 (ru) Хинолинилпирролопиразолы
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
ATE510553T1 (de) Beta-2-glycoprotein 1 als angiogenesehemmer
ATE430572T1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
PA8453601A1 (es) Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para tratamiento del cancer
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
DE60019121D1 (de) Kaliumkanäleöffner
BR0315942A (pt) Tratamento de doenças e condições mediadas pelo aumento de fosforilação
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
EA200100930A1 (ru) Способ лечения хозл
SE0100684D0 (sv) New subject-matter
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ECSP982539A (es) INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER